tiprankstipranks
GRI Bio (GRI)
NASDAQ:GRI
US Market
Holding GRI?
Track your performance easily

GRI Bio (GRI) Financial Statements

167 Followers

GRI Bio Financial Overview

GRI Bio's market cap is currently ―. The company's EPS TTM is $-51.875; its P/E ratio is -0.01; GRI Bio is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.12M$ -2.26M$ -1.89M$ -6.75M$ -2.15M
EBITDA$ -2.12M$ -2.26M$ -1.87M$ -5.79M$ -976.00K
Net Income Common Stockholders$ -2.12M$ -2.25M$ -1.89M$ -6.75M$ -2.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.75M$ 6.35M$ 4.09M$ 4.80M$ 1.67M
Total Assets$ 5.46M$ 7.03M$ 4.59M$ 5.64M$ 2.10M
Total Debt$ 131.00K$ 141.00K$ 152.00K$ 41.00K$ 0.00
Net Debt$ -4.62M$ -6.21M$ -3.94M$ -4.76M$ -1.67M
Total Liabilities$ 1.80M$ 2.31M$ 1.79M$ 1.60M$ 2.07M
Stockholders Equity$ 3.66M$ 4.72M$ 2.80M$ 4.04M$ 31.00K
Cash Flow-
Free Cash Flow$ -2.27M$ -2.14M$ -2.20M$ -1.55M$ -579.00K
Operating Cash Flow$ -2.27M$ -2.14M$ -2.20M$ -1.54M$ -579.00K
Investing Cash Flow---$ -8.00K-
Financing Cash Flow$ 661.00K$ 4.40M$ 4.49M$ 5.89M$ 1.03M
Currency in USD

GRI Bio Earnings and Revenue History

GRI Bio Debt to Assets

GRI Bio Cash Flow

GRI Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis